Adiponectin suppresses tumor growth of nasopharyngeal carcinoma through activating AMPK signaling pathway

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Endogenous production of n −3 polyunsaturated fatty acids protects mice from carbon tetrachloride‐induced liver fibrosis by regulating mTOR and Bcl‐2/Bax signalling pathways

(2021) Changfeng Shan et al.   EXPERIMENTAL PHYSIOLOGY

AdipoRon improves cognitive dysfunction of Alzheimer’s disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway

(2020) Bin Liu et al.   EXPERIMENTAL NEUROLOGY

A gene-expression predictor for efficacy of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma

(2020) Yuan Lei et al.   JNCI-Journal of the National Cancer Institute

Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers

(2020) Chunmei Fan et al.   BMC CANCER

Body mass index, body shape, and risk of nasopharyngeal carcinoma: A population-based case-control study in Southern China

(2019) Ruimei Feng et al.   Cancer Medicine

Nasopharyngeal carcinoma

(2019) Yu-Pei Chen et al.   LANCET

Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study

(2018) Xin-Ran Tang et al.   LANCET ONCOLOGY

Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis

(2018) Miho Akimoto et al.   Cell Death & Disease

Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression

(2018) Sarah Nicolas et al.   Translational Psychiatry

Obesity and cancer risk: Emerging biological mechanisms and perspectives

(2018) Konstantinos I. Avgerinos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Risk of nasopharyngeal carcinoma penetrates across immigrant generations: A migrant cohort study of 2.3 million Jewish Israeli adolescents

(2017) Yakir Rottenberg et al.   INTERNATIONAL JOURNAL OF CANCER

Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

(2017) Li Zhang et al.   MOLECULAR CANCER RESEARCH

Obesity, Inflammation, and Cancer

(2016) Tuo Deng et al.   Annual Review of Pathology-Mechanisms of Disease

Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals

(2016) Jonathan N. Hofmann et al.   CANCER RESEARCH

AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings

(2015) Yanqing Zhang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Critical Role of AMPK/FoxO3A Axis in Globular Adiponectin-Induced Cell Cycle Arrest and Apoptosis in Cancer Cells

(2015) Anup Shrestha et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma

(2015) Hao Bo et al.   Oncotarget

Targeting AMPK for cancer prevention and treatment

(2015) Weidong Li et al.   Oncotarget

Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis

(2014) Yingna Bao et al.   CELL CYCLE

DNA aneuploidy-specific therapy for head and neck squamous cell carcinoma

(2014) Jorge García Martínez et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Choline and betaine intakes are associated with reduced risk of nasopharyngeal carcinoma in adults: a case–control study

(2013) F-f Zeng et al.   BRITISH JOURNAL OF CANCER

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

(2013) Miki Okada-Iwabu et al.   NATURE

Two Epstein-Barr Virus-Related Serologic Antibody Tests in Nasopharyngeal Carcinoma Screening: Results From the Initial Phase of a Cluster Randomized Controlled Trial in Southern China

(2012) Z. Liu et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The Role of Adiponectin in Cancer: A Review of Current Evidence

(2012) Maria Dalamaga et al.   ENDOCRINE REVIEWS

Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China

(2011) Yue Liu et al.   INTERNATIONAL JOURNAL OF CANCER

Suppression of Liver Tumor Growth and Metastasis by Adiponectin in Nude Mice through Inhibition of Tumor Angiogenesis and Downregulation of Rho Kinase/IFN-Inducible Protein 10/Matrix Metalloproteinase 9 Signaling

(2010) K. Man et al.   CLINICAL CANCER RESEARCH

AMPK as a metabolic tumor suppressor: control of metabolism and cell growth

(2010) Zhijun Luo et al.   Future Oncology

Adiponectin Represses Colon Cancer Cell Proliferation via AdipoR1- and -R2-Mediated AMPK Activation

(2010) A Young Kim et al.   MOLECULAR ENDOCRINOLOGY

A 25-Year Prospective Study of Plasma Adiponectin and Leptin Concentrations and Prostate Cancer Risk and Survival

(2009) H. Li et al.   CLINICAL CHEMISTRY

Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China

(2009) Xiuchan Guo et al.   INTERNATIONAL JOURNAL OF CANCER

LKB1 is required for adiponectin-mediated modulation of AMPK–S6K axis and inhibition of migration and invasion of breast cancer cells

(2009) L Taliaferro-Smith et al.   ONCOGENE

The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma

(2008) Shikha Bose et al.   JOURNAL OF PATHOLOGY